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Literature search strategy 
 
1.0 RESEARCH OBJECTIVES 
 
1.1 Background 
 
With a strong pipeline of 15 novel tuberculosis (TB) vaccine candidates in clinical trials,1 there is a 
growing modelling literature exploring the potential impact of novel TB vaccines. Such models can 
be used to inform decision making with regards to the characteristics and target population for 
novel vaccines, to allow limited funding to be appropriately prioritised to ensure the greatest 
public health impact would be achieved when new vaccines come to market. To-date, the body of 
literature on this topic has not been summarised. The objective of this review is to narratively 
summarise the methodology and outcomes from modelling research exploring the epidemiological 
impact of pipeline or theoretical TB vaccines.  
 
1.2 Research Question 
 
What are the methods and estimated epidemiological impact of pipeline or theoretical human 
tuberculosis vaccines as estimated by mathematical modelling? 
 
The PICOT framework for this research question is as follows: 
 
Table 1: PICOT question 
Limit Definition 
Population Humans, of any age in any country or globally 
Intervention 
Novel/theoretical/pipeline TB vaccines 
Not BCG-only 
Comparator 
No intervention, currently available interventions (at current or scaled-up 
levels), or other theoretical interventions. 
Outcome 
Tuberculosis epidemiological impact (e.g. incidence, prevalence, mortality, 
number needed to vaccinate, cost effectiveness) 
Not Mycobacterium bovis 
Time No limit 
Methodology 
Epidemiological mathematical models 
Not within-host impact models 
Not reviews/commentaries 
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2.0 METHODS 
 
2.1 Search Strategy 
 
Three databases (Pubmed, Embase and WHO Global Index Medicus (GIM)) providing access to 
seven databases/indexes (Pubmed/Medline, Embase, African Index Medicus, LILACS, SEARO Index 
Medicus, WPRO Index Medicus, EMRO Index Medicus) will be searched. Searches will use free text 
and Mesh/Emtree/DeCS terms tailored by database for groups of terms covering tuberculosis, 
modelling and vaccines (table 2). Search terms are combined with Boolean OR within groups, and 
by Boolean AND between search term groups. The search in Pubmed will be run with filter 
“human”, and the WHO GIM search will be limited to regional databases to avoid duplication. 
 
 
Table 2: Search terms by database 
Database 
Search Term Group 
Modelling Tuberculosis Vaccine 
Pubmed 
"Models, 
Theoretical"[Mesh]) OR 
"mathematical model*" 
TB OR tuberculosis OR 
"Tuberculosis"[Mesh] 
vaccin* OR immuniz* OR 
immunis* OR 
"Tuberculosis 
Vaccines"[Mesh] 
Embase 
("mathematical 
model$".mp. OR 
mathematical 
model.mp. or 
mathematical model/) 
(tuberculosis control/ or 
exp tuberculosis/ or 
Mycobacterium 
tuberculosis/ or tb.mp. 
or tuberculosis.mp.) 
 
(exp vaccine/ or (vaccin$ 
or immunis$ or 
immuniz$).mp.) 
 
WHO Global 
Index Medicus 
(regional 
databases) 
("computer models" OR 
"epidemiologic models" 
OR "mathematical 
models") 
TB OR tuberculosis OR 
"tuberculosis" 
Not required as very few 
hits with first two search 
terms 
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Table 3: Application of PICOT through search limits and manual search criteria 
Limit Definition Limit management 
Population  
Humans, of any age in any country or 
globally 
“Human” search limit (pubmed 
only) and manual search criterion 
Intervention  
Novel/theoretical/pipeline TB vaccines 
Not BCG-only 
Vaccine search terms and manual 
search criteria 
Comparator  
No intervention, currently available 
interventions (at current or scaled-up 
levels), or other theoretical interventions. 
Manual search criteria 
Outcome  
Tuberculosis epidemiological impact (e.g. 
incidence, prevalence, mortality, number 
needed to vaccinate, cost effectiveness) 
Not Mycobacterium bovis 
TB search terms and manual 
search criteria 
 
Time  No limit No limit applied 
Methodology  
Epidemiological mathematical models 
Not within-host impact models 
Not reviews/commentaries 
Modelling search terms manual 
search criteria 
 
 
 
2.2 Selection of studies and data extraction 
 
The database searching, sifting and data extraction will be conducted in by a single reviewer (RCH). 
A three-stage sifting process will be employed to screen publications first at title, abstract, then at 
full text level for eligibility for inclusion using the below-details inclusion and exclusion criteria. 
Any uncertainties in inclusion will be decided through discussion with a second reviewer (RW). 
Reference lists of included studies will be hand searched for studies meeting the inclusion criteria. 
Onward citation searching will be conducted for all included articles. 
 
 
Inclusion Criteria 
 Mathematical model 
 Systematic review of models of novel TB vaccines, or commentary adding to the 
analyses/interpretation of models reported elsewhere 
 Intervention is novel/future/hypothetical vaccine against tuberculosis or of an unspecified 
novel TB intervention with characteristics in-line with a vaccine 
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 Reported outcomes are of epidemiological impact of vaccine (e.g. incidence, prevalence, 
mortality, number needed to vaccinate, cost effectiveness) 
 
Exclusion Criteria 
 Within-host/immunological vaccine impact models 
 Review or commentary not adding to existing body of knowledge 
 TB epidemiological models not reporting impact of vaccine  
 TB epidemiological models reporting only interventions other than vaccines 
 Model only reporting on impact of BCG with known/fixed efficacy 
 Disease or infection caused by Mycobacterium bovis or other non-Mycobacterium 
tuberculosis strain. 
 
Data will be extracted from those papers selected for final inclusion using a standardised 
Microsoft Excel® database. Extracted data will include study objectives, model methods (e.g. 
model structure, mixing patterns, model assumptions, parameter data sources), intervention 
characteristics (e.g. vaccine efficacy, duration of protection, waning of protection, vaccine target 
population and schedule), epidemiological outcomes, sensitivity analyses, and model limitations. 
 
3.0 QUALITY ASSESSMENT AND DATA SYNTHESIS  
3.1 Quality Assessment 
Few validated tools exist for the assessment of quality of epidemiological modelling studies. Fone 
et al. (2003) have proposed and tested an adapted version of the Weightman et al. (2000) tool for 
the critical appraisal of the quality of modelling studies in health care.2,3 And more recently Caro et 
al. have detailed the criteria for good research practice in modelling research.4 In this review, the 
Fone et al. tool will be used as a basis for quality assessment, but updated based upon the Caro et 
al. report to ensure clarity and coverage of certain criteria.2,4 Based upon extracted data, each 
included article will be critically appraised for quality using a piloted version of this extraction 
form. 
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3.2 Data Synthesis 
Extracted data will be synthesised using a narrative approach and will focus on the modelling 
methods used, estimates of epidemiological impact, and identifying evidence gaps or limitations.  
3.3 Dissemination 
The review manuscript will be submitted for publication in a peer reviewed journal. 
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